Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Family Medicine
 Disease Category: Hematologic Cancer
Location: United States, CA

Trial Information

Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study(Under CFR 312.34)

You have/your child has been asked to participate in this research study because you have/your child has hepatic veno-occlusive disease (VOD). The primary objective of this study is to provide Defibrotide to patients with VOD. At present there is no established curative therapy for hepatic VOD. You/your child’s treatment on this study is expected to last at least 21 days and will continue until you/your child’s disease resolves or you/your child is ready to leave the hospital, as circumstances allow.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.